Latus Motors Racing is pleased to announce that Kody Kopp will return to competition for the 2026 Progressive American Flat Track season ...
Latus Bio Inc. has reported IND clearance by the FDA for LTS-101, a gene therapy candidate to treat the CNS manifestations of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback